JAPANESE CIRCULATION JOURNAL
Online ISSN : 1347-4839
Print ISSN : 0047-1828
ISSN-L : 0047-1828
Experimental Study
Protective Effect of Captopril on Ischemic Myocardium
Toshikuni YanagishitaMasataka TomitaSeiji ItohShuji MukaeHirohisa ArataHaruhiko IshiokaEiichi GeshiNoburu KonnoTakashi Katagiri
Author information
JOURNAL FREE ACCESS

1997 Volume 61 Issue 2 Pages 161-169

Details
Abstract

The protective effect and mechanism of action of the angiotensin-converting enzyme inhibitor (ACE-I) captopril was investigated in organelles from ischemic myocardial cells in a canine coronary ligation model. Sarcoplasmic reticulum (SR) and mitochondrial fractions were extracted from ischemic and nonischemic myocardial cells from captopril- and saline-treated (control) hearts. Heart rate, cardiac output, and right ventricular systolic blood pressure were similar in the captopril-treated and control groups. Left ventricular systolic blood pressure (LVPs) decreased gradually to 89% of the baseline value after captopril administration, and to 78% of the baseline value after ligation. Ca-ATPase activity in the SR, the respiratory control ratio (RCR) in the mitochondria, and dinitrophenol (DNP)-stimulated ATPase activity were significantly higher in ischemic myocardium from the captopril-treated group than from the saline-treated (control) group. The SH group content of both organelles was higher in the captopril-treated group. Our results suggest that, in addition to their hemodynamic effects, ACE-I agents containing SH groups protect the myocardium from ischemic damage by preventing enzyme oxidation. (Jpn Circ J 1997; 61: 161 - 169)

Content from these authors
© 1997 THE JAPANESE CIRCULATION SOCIETY
Previous article Next article
feedback
Top